GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.
GENinCod has raised €586k across 1 funding round from 1 investor, most recently a round in Aug 2021. Based in Oxford, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-03 | Other | €586k |
| Maven Capital Partners |
| View deal → |
